LASA

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹6.69

-1.91% today · 30d -13.79%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for LASA. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹1 Cr

-93.87% YoY

NET PROFIT

₹-4 Cr

OPM

-97.51%

-95.68pp YoY

EPS

₹0.71

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-69.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

LASA——

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 20

Valuation — —

Growth DECLINING 26

Profitability LOW 5

Technicals WEAK 30

Risk LOW 90

Key Stats

P/B

0.68

52W HIGH

₹14.08

OFF HIGH

-52.49%

MKT CAP

₹33 Cr

◉ Active Signals

MACDBearish-0.0411

RSI(14)Bearish38.86

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold LASA and at what entry.